Immediate respiratory management of the preterm infant

Seminars in Fetal and Neonatal Medicine

Volumn 13, Issue 1, 2008, Pages 24-29

  Sinha, Sunil K ^a,b   Gupta, Samir ^b   Donn, Steven M ^c  

^a DURHAM UNIVERSITY   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Chronic lung disease; Continuous positive airway pressure (CPAP); Prematurity; Respiratory distress syndrome (RDS); Surfactant

Indexed keywords

BERACTANT; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; PORACTANT; PUMACTANT; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; DRUG EFFICACY; HUMAN; INFANT; NEBULIZER; NEONATAL RESPIRATORY DISTRESS SYNDROME; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RESUSCITATION;

ADMINISTRATION, INHALATION; AEROSOLS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESUSCITATION;

EID: 37349108211     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.09.006     Document Type: Article

References (26)

1. Sinha S.K., and Donn S.M. Fetal-to-neonatal maladaptation. Semin Fetal Neonatal Med 11 (2006) 166-173
2. Bhutani V.K. Development of respiratory system. In: Donn S.M., and Sinha S.K. (Eds). Manual of neonatal respiratory care (2006), Mosby Elsevier, Philadelphia 3-10
3. Donn S.M., and Sinha S.K. Minimising ventilator induced lung injury in preterm infants. Arch Dis Child Fetal Neonatal Ed 91 (2006) F226-F230
4. Halamek L.P., and Morley C. Continuous positive airway pressure during neonatal resuscitation. Clin Perinatol 33 (2006) 83-98
5. Yost C.C., and Soll R.F. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 4 (1999) CD001456
6. Sinha S.K., Moya F., and Donn S.M. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?. Curr Opin Pediatr 19 (2007) 150-154
7. Moya F., and Maturana A. Animal-derived surfactants versus past and current synthetic surfactants: current status. Clin Perinatol 34 (2007) 145-177
8. Moya F., Sinha S., Gadzinowski J., et al. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials. Pediatrics 119 (2007) e1361-e1370
9. Probyn M.E., Hooper S.B., Dargaville P.A., et al. Positive end expiratory pressure during resuscitation of premature lambs rapidly improves blood gases without adversely affecting arterial pressure. Pediatr Res 56 (2004) 198-204
10. Jobe A.H., Kramer B.W., Moss T.J., Newnham J.P., and Ikegami M. Decreased indicators of lung injury with continuous positive airway pressure in preterm lambs. Pediatr Res 52 (2002) 387-392
11. Michna J., Jobe A.H., and Ikegami M. Positive end-expiratory pressure preserves surfactant function in preterm lambs. Am J Resp Crit Care Med 160 (1999) 634-639
12. Mulrooney N., Champion Z., Moss T.J., Nitsos I., Ikegami M., and Jobe A.H. Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med 171 (2005) 488-493
13. Schlessel J.S., Susskind H., Joel D.D., et al. Effect of PEEP on regional ventilation and perfusion in mechanically ventilated preterm lamb. J Nucl Med 30 (1989) 1342-1350
14. Finer N.N., Carlo W.A., Duara S., et al. Delivery room continuous positive airway pressure/positive end expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 114 (2004) 651-657
15. Davis P.G., and Henderson-Smart D.J. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2 (2003) CD000143
16. Avery M.E., Tooley W.H., Keller J.B., et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centres. Pediatrics 79 (1987) 26-30
17. Van Marter L.J., Allred E.N., Pagano M., et al. Do clinical markers of barotraumas and oxygen toxicity explain interhospital variation in rates of chronic lung disease?. Pediatrics 105 (2000) 119-201
18. de Paoli A.G., Morley C., and Davis P.G. Nasal CPAP for neonates: what do we know in 2003?. Arch Dis Child Fetal Neonatal Ed 88 (2003) 168-172
19. Ammari A., Suri M., Milisavljevic V., et al. Variables associated with early failure of nasal CPAP in very low birth weight infants. J Pediatr 147 (2005) 341-347
20. Verder H., Robertson B., Greisen G., et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 331 (1994) 1051-1055
21. Verder H., Albertsen P., Ebbesen F., et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 130 (1999) e24
22. Thomson M.A. Early nasal CPAP + prophylactic surfactant for neonates at risk of RDS. The IFDAS trial. (abstract). Pediatr Res 50 (2001) 304A
23. Morley CJ, COIN trial collaborators. Nasal CPAP or ventilation for very preterm infants at birth: a randomised controlled trial - The COIN trial. E-PAS 2007;61:6090.1.
24. Finer N. To intubate or not - that is the question: continuous positive airway pressure versus surfactant and extremely low birth weight infants. Arch Dis Child Fetal Neonatal Ed 91 (2006) F392-F394
25. Mazela J., Merritt T.A., and Finer N.N. Aerosolized surfactants. Curr Opin Pediatr 19 (2007) 155-162
26. Finer NN, Merritt TA, Bernstein G, Job L. A multicenter, pilot study of Aerosurf™ delivered via nasal CPAP to prevent RDS in pre-term neonates. EPAS 2006;59:4840.138.